Skip to main content
See every side of every news story
Published • loading... • Updated

NRx Pharmaceuticals starts ketamine sales effort

Hospital sales outreach has begun ahead of January deliveries as NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) said on Wednesday it activated a 17-person team for U.S.-made preservative-free ketamine. NRx expects gross and net sales margins above 50 per cent, although the launch release discloses no product price or purchase quantities. The Nov. 11 announcement targets initial supply agreements and preorders in late 2026, followed by shipments in Jan…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Mugglehead Magazine broke the news in Vancouver, Canada on Wednesday, November 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal